South Korea · Delayed Price · Currency is KRW Daelim Bath Statistics
Total Valuation
Daelim Bath has a market cap or net worth of KRW 92.94 billion. The enterprise value is 152.14 billion.
| Market Cap | 92.94B |
| Enterprise Value | 152.14B |
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Daelim Bath has 16.42 million shares outstanding. The number of shares has decreased by -1.07% in one year.
| Current Share Class | 16.42M |
| Shares Outstanding | 16.42M |
| Shares Change (YoY) | -1.07% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 56.05% |
| Owned by Institutions (%) | n/a |
| Float | 5.55M |
Valuation Ratios
The trailing PE ratio is 6.97.
| PE Ratio | 6.97 |
| Forward PE | n/a |
| PS Ratio | 0.31 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | 8.05 |
| P/OCF Ratio | 6.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.63, with an EV/FCF ratio of 13.18.
| EV / Earnings | 11.37 |
| EV / Sales | 0.51 |
| EV / EBITDA | 5.63 |
| EV / EBIT | 8.32 |
| EV / FCF | 13.18 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.44.
| Current Ratio | 1.06 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | 2.84 |
| Debt / FCF | 6.67 |
| Interest Coverage | 5.18 |
Financial Efficiency
Return on equity (ROE) is 7.98% and return on invested capital (ROIC) is 6.01%.
| Return on Equity (ROE) | 7.98% |
| Return on Assets (ROA) | 3.35% |
| Return on Invested Capital (ROIC) | 6.01% |
| Return on Capital Employed (ROCE) | 8.36% |
| Weighted Average Cost of Capital (WACC) | 5.08% |
| Revenue Per Employee | 429.38M |
| Profits Per Employee | 19.11M |
| Employee Count | 700 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 4.36 |
Taxes
In the past 12 months, Daelim Bath has paid 5.07 billion in taxes.
| Income Tax | 5.07B |
| Effective Tax Rate | 27.28% |
Stock Price Statistics
The stock price has increased by +40.80% in the last 52 weeks. The beta is 0.41, so Daelim Bath's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +40.80% |
| 50-Day Moving Average | 5,514.00 |
| 200-Day Moving Average | 4,825.60 |
| Relative Strength Index (RSI) | 51.26 |
| Average Volume (20 Days) | 137,231 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Daelim Bath had revenue of KRW 300.57 billion and earned 13.37 billion in profits. Earnings per share was 812.00.
| Revenue | 300.57B |
| Gross Profit | 82.57B |
| Operating Income | 18.41B |
| Pretax Income | 18.57B |
| Net Income | 13.37B |
| EBITDA | 27.15B |
| EBIT | 18.41B |
| Earnings Per Share (EPS) | 812.00 |
Balance Sheet
The company has 26.53 billion in cash and 77.03 billion in debt, with a net cash position of -50.50 billion or -3,075.30 per share.
| Cash & Cash Equivalents | 26.53B |
| Total Debt | 77.03B |
| Net Cash | -50.50B |
| Net Cash Per Share | -3,075.30 |
| Equity (Book Value) | 176.53B |
| Book Value Per Share | 10,220.98 |
| Working Capital | 7.53B |
Cash Flow
In the last 12 months, operating cash flow was 13.51 billion and capital expenditures -1.97 billion, giving a free cash flow of 11.54 billion.
| Operating Cash Flow | 13.51B |
| Capital Expenditures | -1.97B |
| Depreciation & Amortization | 8.74B |
| Net Borrowing | -16.20B |
| Free Cash Flow | 11.54B |
| FCF Per Share | 702.95 |
Margins
Gross margin is 27.47%, with operating and profit margins of 6.12% and 4.45%.
| Gross Margin | 27.47% |
| Operating Margin | 6.12% |
| Pretax Margin | 6.18% |
| Profit Margin | 4.45% |
| EBITDA Margin | 9.03% |
| EBIT Margin | 6.12% |
| FCF Margin | 3.84% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 2.65%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 2.65% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 18.70% |
| Buyback Yield | 1.07% |
| Shareholder Yield | 3.71% |
| Earnings Yield | 14.39% |
| FCF Yield | 12.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Daelim Bath has an Altman Z-Score of 1.93 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 6 |